HomeCompareHLBBF vs VIG

HLBBF vs VIG: Dividend Comparison 2026

HLBBF yields 2.10% · VIG yields 1.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIG wins by $12.3K in total portfolio value
10 years
HLBBF
HLBBF
● Live price
2.10%
Share price
$6.18
Annual div
$0.13
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.21
Full HLBBF calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.64%
Share price
$210.70
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.4K
Annual income
$179.15
Full VIG calculator →

Portfolio growth — HLBBF vs VIG

📍 VIG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLBBFVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLBBF + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLBBF pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLBBF
Annual income on $10K today (after 15% tax)
$178.66/yr
After 10yr DRIP, annual income (after tax)
$0.18/yr
VIG
Annual income on $10K today (after 15% tax)
$139.33/yr
After 10yr DRIP, annual income (after tax)
$152.28/yr
At 15% tax rate, VIG beats the other by $152.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLBBF + VIG for your $10,000?

HLBBF: 50%VIG: 50%
100% VIG50/50100% HLBBF
Portfolio after 10yr
$26.2K
Annual income
$89.68/yr
Blended yield
0.34%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLBBF buys
0
VIG buys
0
No recent congressional trades found for HLBBF or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLBBFVIG
Forward yield2.10%1.64%
Annual dividend / share$0.13$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$20.0K$32.4K
Annual income after 10y$0.21$179.15
Total dividends collected$211.00$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HLBBF vs VIG ($10,000, DRIP)

YearHLBBF PortfolioHLBBF Income/yrVIG PortfolioVIG Income/yrGap
1← crossover$10,805$105.09$11,304$163.92$499.00VIG
2$11,615$53.06$12,759$166.33$1.1KVIG
3$12,454$26.65$14,382$168.52$1.9KVIG
4$13,339$13.36$16,192$170.52$2.9KVIG
5$14,280$6.68$18,210$172.34$3.9KVIG
6$15,283$3.34$20,460$173.98$5.2KVIG
7$16,354$1.67$22,968$175.48$6.6KVIG
8$17,500$0.84$25,763$176.83$8.3KVIG
9$18,725$0.42$28,878$178.05$10.2KVIG
10$20,036$0.21$32,350$179.15$12.3KVIG

HLBBF vs VIG: Complete Analysis 2026

HLBBFStock

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

Full HLBBF Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this HLBBF vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLBBF vs SCHDHLBBF vs JEPIHLBBF vs OHLBBF vs KOHLBBF vs MAINHLBBF vs DGROHLBBF vs NOBLHLBBF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.